Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant.
Carlini
A
A
Department of Nephrology, Campo di Marte Hospital, Lucca, Italy.
Angelini
D
D
Burrows
L
L
De Quirico
G
G
Antonelli
A
A
D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D001922:Brain Abscess / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D004337:Drug Carriers; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation; D008081:Liposomes; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D012449:Safety
D000935:Antifungal Agents; D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B